Stress and Coping, Resilience, and Compassion Fatigue of Front-line Nurses During COVID-19 Pandemic

January 25, 2022 updated by: Piao-Yi Chiou, National Taiwan University

The Correlation of Stress and Coping, Resilience, and Compassion Fatigue of Nurses Staying on Front-line During COVID-19 Outbreak in Taiwan

This is a cross-sectional research. The investigators plan to recruit about 250 front-line nurses who provided direct care to COVID-19 confirmed cases in a medical center in Taiwan. Online querstionnaires are used to collect the data. The relationship between variables such as stressors related to COVID-19, coping status, resilience, and compassion fatigue of participants will be analysis to provide the direction of nurses' mental health-related interventions.

Study Overview

Status

Recruiting

Conditions

Intervention / Treatment

Detailed Description

This project aims to identify the prevalence of compassion fatigue and the coping strategies for the nurses who work on the frontline of healthcare and are responsible for caring for patients with COVID-19 in Taiwan. The investigators planed to carry a cross-sectional study by a reliable and valid online questionnaire to explore the stressors related to COVID-19, coping status, resilience, and compassion fatigue of nurses who had the experience of caring for the COVID-19 confirmed cases in a medical center during the community outbreak in Taiwan from May 2021. Online questionnaires are used to collect the data. About two hundred and fifty nurses will be recruited, and the data will be analyzed by descriptive statistics, correlation statistics and Hayes's PROCESS model 6. It is expected that the research results can understand the current status and relationship of compassion fatigue, resilience and the adaptability of clinical nurses who are caring for the COVID-19 confirmed cases. The results can be contributed to develop the direction of nurses' mental health-related interventions during pandemic of emerging contagious disease.

Study Type

Observational

Enrollment (Anticipated)

250

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

  • Name: PIAO-YI CHIOU, doctoral
  • Phone Number: 88427 +886-2-23123456
  • Email: piaoyi@ntu.edu.tw

Study Contact Backup

Study Locations

  • Taiwan
      • Taipei, Taiwan, 100
        • Recruiting
        • School of Nursing of National Taiwan University
        • Contact:
          • PIAO-YI CHIOU, doctoral
          • Phone Number: 88427 +886-2-23123456
          • Email: piaoyi@ntu.edu.tw
    • Zhongzheng Dist.
      • Taipei City, Zhongzheng Dist., Taiwan, 100225
        • Recruiting
        • National Taiwan University Hospital
        • Contact:
      • Taipei City, Zhongzheng Dist., Taiwan, 100
        • Recruiting
        • National Taiwan University Hospital
        • Contact:

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

20 years and older (Adult, Older Adult)

Accepts Healthy Volunteers

Yes

Genders Eligible for Study

All

Sampling Method

Non-Probability Sample

Study Population

Clinical nurses who have been or are still working in hospital, and have directly cared for COVID-19 confirmed cases from May 2021.

Description

Inclusion Criteria:

  • Above/include 20-year-old.
  • Those who can operate mobile communication software or computers and can fill in online questionnaires.
  • Clinical nurses who had provided nursing care for COVID-19 confirmed cases from May 2021.

Exclusion Criteria:

  • Those who did not provide nursing care for COVID-19 confirmed cases.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Interaction effect between research variables
Time Frame: six months to collect and analysis data.
Factors including "stressors related to COVID-19", "stress coping", "resilience", and "compassion fatigue" have interaction effect.
six months to collect and analysis data.
Moderation effect between research variables
Time Frame: six months to collect and analysis data.
Both "stress coping" and "resilience" moderate the strength relationship between "stressors" and "compassion fatigue".
six months to collect and analysis data.

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Sponsor

National Taiwan University

Collaborators

National Taiwan University Hospital

Investigators

  • Principal Investigator: YI-CHEN YEH, Bachelor, National Taiwan University Hospital

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

January 25, 2022

Primary Completion (Anticipated)

June 30, 2022

Study Completion (Anticipated)

July 31, 2022

Study Registration Dates

First Submitted

January 21, 2022

First Submitted That Met QC Criteria

January 21, 2022

First Posted (Actual)

January 25, 2022

Study Record Updates

Last Update Posted (Actual)

February 9, 2022

Last Update Submitted That Met QC Criteria

January 25, 2022

Last Verified

January 1, 2022

More Information

Terms related to this study

Keywords

Additional Relevant MeSH Terms

Other Study ID Numbers

  • 202106153RINB

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on COVID-19 Pandemic

Clinical Trials on This is a cross-sectional research design.

Search Similar Trials

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Togo

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations

3
Subscribe